Loading ...

PEGylated cholesterol/dimyristoylphosphatidylcholine liposomes having calcium acetate solution core

Based on

1 Patents
2013 Most recent source

Composition

1

calcium acetate solution

Type Complex Compound
Formula
Role core
2

(2R)-2,3-bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate

1,2-dimyristoyl-sn-glycero-3-phosphocholine dimyristoyl-2-hydroxy-sn-glycero-3-phosphocholine 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine 1,2-dinonadecanoyl-sn-glycero-3-phosphocholine 1,2-dimyristoyl-sn-glycero-3- phosphocholine 1,2-dimyristoyl-sn-glycero-3-phosphocholine 2-dimyristoyl-sn-glycero-3-phosphocholine dimyristoyl-sn-glycero-3-phosphocholine L-α-dimyristoylphosphatidylcholine dimyristoyl phosphatidylcholine dimyristoylphosphatidylcholine di-14:0PC DMPC DMPE
Type Single Compound
Formula C36H72NO8P
Role layer
3

cholesterol

Type Single Compound
Formula C27H46O
Role loaded material
4

DSPE-PEG-GSH

Type Polymer
Formula
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
PD 150606 encapsulation efficiency

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • calcium acetate solution
  • DSPE-PEG-GSH
  • water
  1. IPDNUzK
Product

PEGylated cholesterol/dimyristoylphosphatidylcholine liposomes having calcium acetate solution core

Size: ~ 100 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial